Ayala Pharmaceuticals Inc (ADXS)

[Meishairwin]

Dear BlueEyed,

If you truly believe "Dan must go," then you really ought to sell your position in the company because Dan's moves have worked and the technology is progressing. ADXS board is not going to replace Dan.

To expect the share price of an early stage biotech to progress evenly upwards prior to Ph3 approval is simply not realistic in this segment. Only when Ph3 approval comes will share price increase significantly and permanently -- and that's a ways down the road.

Dan has raised funds to keep this company very stable and capable of making deals from strength and the share price is above where it was in January 2015 when biotechs went into their irrational bubble. Anyone who bought this equity after March 1, 2015 got caught in that bubble -- which is not Dan's fault. Anyone who bought before then has done well or is at least even, which is saying a lot for such an early stage biotech.

I don't find any of the arguments for Dan's fund raising being ill-considered to be well-considered... most are whining without the facts or analysis they'd need to make a convincing case.

If I were on the ADXS Board, I would be doing everything I could to encourage Dan to keep moving things along the way he has.